Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TNGX Tango Therapeutics Inc.

交易中 03-25 10:23:03 EDT

20.58

+1.10

+5.65%

最高20.80	最低19.60	成交量46.82万
今开19.60	昨收19.48	日振幅6.16%
总市值29.37亿	流通市值12.30亿	总股本1.43亿
成交额952.16万	换手率0.78%	流通股本5,976万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TNGX","market":"US","secType":"STK","nameCN":"Tango Therapeutics Inc.","latestPrice":20.58,"timestamp":1774448570895,"preClose":19.48,"halted":0,"volume":468218,"delay":0,"changeRate":0.056468172484599476,"floatShares":59756899,"shares":142688851,"eps":-0.874557,"marketStatus":"交易中","change":1.1,"latestTime":"03-25 10:23:03 EDT","open":19.6,"high":20.8,"low":19.6,"amount":9521559.979538,"amplitude":0.061602,"askPrice":20.62,"askSize":491,"bidPrice":20.54,"bidSize":201,"shortable":3,"etf":0,"ttmEps":-0.874557,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"listingDate":1599105600000,"exchange":"NASDAQ","adjPreClose":19.48,"preHourTrading":{"tag":"盘前","latestPrice":19.71,"preClose":19.48,"latestTime":"09:29 EDT","volume":579,"amount":11307.149145,"timestamp":1774445399999,"change":0.23,"changeRate":0.011807,"amplitude":0.031314},"postHourTrading":{"tag":"盘后","latestPrice":19.5606,"preClose":19.48,"latestTime":"19:06 EDT","volume":70631,"amount":1378126.2,"timestamp":1774393584207,"change":0.0806,"changeRate":0.004138,"amplitude":0.031828},"volumeRatio":0.850248,"impliedVol":0.8674,"impliedVolPercentile":0.4741},"requestUrl":"/m/hq/s/TNGX","defaultTab":"news","newsList":[{"id":"1178136199","title":"异动解读 | Tango Therapeutics与Erasca达成临床合作，股价盘中大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178136199","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178136199?lang=zh_cn&edition=full","pubTime":"2026-03-05 22:55","pubTimestamp":1772722559,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.今日盘中大涨5.10%，引起了市场的广泛关注。消息面上，Tango Therapeutics与生物制药公司Erasca, Inc.宣布建立临床合作，将共同开展针对ERAS-0015与vopimetostat联合疗法的临床评估。双方计划通过临床研究验证联合方案的协同效应，重点关注其在特定适应症中的安全性与疗效。这一合作标志着两家公司在肿瘤治疗领域迈出的重要一步，可能为Tango Therapeutics带来长期增长机会。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TNGX"],"gpt_icon":0},{"id":"1109354934","title":"Erasca与Tango Therapeutics达成临床合作，评估ERAS-0015与Vopimetostat联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1109354934","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109354934?lang=zh_cn&edition=full","pubTime":"2026-03-05 20:10","pubTimestamp":1772712605,"startTime":"0","endTime":"0","summary":"生物制药公司Erasca, Inc.（纳斯达克代码：ERAS）与Tango Therapeutics Inc.（纳斯达克代码：TNGX）宣布建立临床合作，将共同开展针对ERAS-0015与vopimetostat联合疗法的临床评估。该合作旨在探索两种创新疗法联用的潜力，为患者提供更有效的治疗选择。\n双方计划通过临床研究验证联合方案的协同效应，重点关注其在特定适应症中的安全性与疗效。这一合作标志着两家公司在肿瘤治疗领域迈出的重要一步，有望加速创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ERAS","TNGX"],"gpt_icon":0},{"id":"1117156505","title":"财报前瞻 ｜Tango Therapeutics Inc.本季度营收预计降93.56%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1117156505","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117156505?lang=zh_cn&edition=full","pubTime":"2026-02-26 10:50","pubTimestamp":1772074216,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc.将在2026年03月05日发布2025年第四季度财报，市场聚焦合作收益的节奏与盈利路径的可持续性。公司上季度财报未披露针对本季度的营收、毛利率、净利率、调整后每股收益的明确指引。发展前景最大的现有业务仍来自合作收益的延续与拓展，上季度在合作收益的驱动下，公司整体营收同比增长363.61%，显示外部合作带来的收入弹性与扩张空间。基于一致预期，本季度营收为50.04万美元，同比降幅达到93.56%，这意味着收入确认可能出现明显的季度波动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"财报前瞻 ｜Tango Therapeutics Inc.本季度营收预计降93.56%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX"],"gpt_icon":0},{"id":"2593734104","title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2593734104","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593734104?lang=zh_cn&edition=full","pubTime":"2025-12-25 06:00","pubTimestamp":1766613621,"startTime":"0","endTime":"0","summary":"杰富瑞近日发布了关于2026年美股生物科技行业的展望报告，聚焦行业首选投资标的、被低估的潜力企业和潜在并购机会。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385521.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"2026美股生物科技板块怎么投资？杰富瑞：关注这6大首选股、7大潜力标的和5大并购目标","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["SLDB","TSHA","LENZ","TNGX","TYRA","ORIC"],"gpt_icon":1},{"id":"1151335344","title":"Tango Therapeutics签署销售协议，提供最高达1亿美元的普通股发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1151335344","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151335344?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:37","pubTimestamp":1763732236,"startTime":"0","endTime":"0","summary":"Tango Therapeutics签署销售协议，提供最高达1亿美元的普通股发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNGX"],"gpt_icon":0},{"id":"1109005368","title":"Tango Therapeutics Inc. - 提交出售170万股的招股说明书 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1109005368","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109005368?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:35","pubTimestamp":1763732114,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc. - 提交出售170万股的招股说明书 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","BK4139"],"gpt_icon":0},{"id":"1146665159","title":"Tango Therapeutics Inc. - 从2025年10月融资获得2.25亿美元的毛收益，使现金流持续到2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1146665159","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146665159?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:12","pubTimestamp":1762265553,"startTime":"0","endTime":"0","summary":"Tango Therapeutics Inc. - 从2025年10月融资获得2.25亿美元的毛收益，使现金流持续到2028年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","BK4139"],"gpt_icon":0},{"id":"2578508330","title":"Tango Therapeutics, Inc.盘中异动 股价大涨5.18%报7.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578508330","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578508330?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:34","pubTimestamp":1761312863,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时34分，Tango Therapeutics, Inc.股票出现异动，股价急速拉升5.18%。截至发稿，该股报7.92美元/股，成交量15.3076万股，换手率0.14%，振幅4.78%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Genenta Science Spa、Inhibrx Biosciences, Inc.、Qualigen Therapeutics, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Neuphoria Therapeutics Inc.、Aditxt, Inc.较为活跃，换手率分别为1695.59%、1317.47%、1118.46%，振幅较大的相关个股有X4制药、Genenta Science Spa、Neuphoria Therapeutics Inc.，振幅分别为36.14%、30.96%、20.99%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。其管道产品是 PRMT5 和 CoREST。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213423a6cc30c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213423a6cc30c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","TNGX"],"gpt_icon":0},{"id":"1125547202","title":"Tango Therapeutics公布Vopimetostat（Tng462）在Mtap缺失癌症患者中进行的1/2期研究积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1125547202","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125547202?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:02","pubTimestamp":1761217330,"startTime":"0","endTime":"0","summary":"Tango Therapeutics公布了Vopimetostat（Tng462）在Mtap缺失癌症患者中进行的1/2期研究的积极数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","BK4139"],"gpt_icon":0},{"id":"2518271986","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518271986?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:13","pubTimestamp":1741619611,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时13分，Tango Therapeutics, Inc.股票出现波动，股价急速跳水5.22%。截至发稿，该股报1.91美元/股，成交量19.5156万股，换手率0.18%，振幅5.97%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3579.63%、960.54%、798.00%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231331abf32200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231331abf32200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TNGX"],"gpt_icon":0},{"id":"2517458219","title":"Tango Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少27.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517458219?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363238,"startTime":"0","endTime":"0","summary":"3月8日，Tango Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少27.45%；其中营业收入为42.07百万美元，同比增加15.17%，每股基本收益为-1.19美元。从资产负债表来看，Tango Therapeutics, Inc.总负债1.29亿美元，其中短期债务2.45百万美元，资产负债比为2.56，流动比率为0.07。机构评级：截至2025年3月8日，当前有7家机构对Tango Therapeutics, Inc.目标价做出预测，其中目标均价为11.29美元，其中最低目标价为8.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000049a2647e68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000049a2647e68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNGX"],"gpt_icon":0},{"id":"2517469959","title":"Tango Therapeutics, Inc.盘中异动 早盘快速拉升9.78%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517469959?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185061,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Tango Therapeutics, Inc.股票出现波动，股价急速上涨9.78%。截至发稿，该股报2.02美元/股，成交量2625股，换手率0.00%，振幅3.26%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.97%、251.30%、183.95%，振幅较大的相关个股有Aditxt, Inc.、4D Molecular Therapeutics, Inc.、Creative Medical Technology Holdings, Inc.，振幅分别为10.04%、8.56%、8.18%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223102989d45ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223102989d45ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TNGX"],"gpt_icon":0},{"id":"2516654942","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.07%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654942?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:13","pubTimestamp":1741025605,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时13分，Tango Therapeutics, Inc.股票出现波动，股价大幅下挫5.07%。截至发稿，该股报1.97美元/股，成交量41.0267万股，换手率0.38%，振幅12.18%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4355.52%、186.47%、179.12%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021325a25d804f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021325a25d804f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","BK4139","LENZ"],"gpt_icon":0},{"id":"2514332991","title":"Tango Therapeutics, Inc.盘中异动 下午盘股价大跌5.12%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332991?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:13","pubTimestamp":1740687198,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时13分，Tango Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。截至发稿，该股报2.21美元/股，成交量29.9409万股，换手率0.28%，振幅7.30%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1921.60%、352.62%、189.60%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041318abdfb94e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228041318abdfb94e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","LENZ","BK4139"],"gpt_icon":0},{"id":"1188823441","title":"探戈治疗公司2024年第四季度GAAP每股收益$(0.35)低于预期$(0.34)，销售额为$4.12百万低于预期$7.77百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1188823441","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188823441?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:12","pubTimestamp":1740658358,"startTime":"0","endTime":"0","summary":"探戈治疗有限公司报告称，季度每股亏损$，低于分析师普遍预期的$，差距为2.94%。相比去年同期销售额$5.43百万，下降了24.19%。以上内容来自Benzinga Earnings专栏，原文如下：Tango $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 2.94 percent. This is a 9.37 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $4.12 million which missed the analyst consensus estimate of $7.77 million by 46.99 percent.  This is a 24.19 percent decrease over sales of","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","LENZ"],"gpt_icon":0},{"id":"2514381851","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大涨5.00%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514381851?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:03","pubTimestamp":1740582197,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时03分，Tango Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。截至发稿，该股报2.42美元/股，成交量8.8658万股，换手率0.08%，振幅7.83%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4654.73%、159.89%、143.13%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262303179893b120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262303179893b120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","LENZ","BK4139"],"gpt_icon":0},{"id":"2512652951","title":"Tango Therapeutics, Inc.盘中异动 股价大涨5.67%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512652951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512652951?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889526,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Tango Therapeutics, Inc.股票出现异动，股价大幅拉升5.67%。截至发稿，该股报2.61美元/股，成交量1.9789万股，换手率0.02%，振幅5.47%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为296.68%、102.78%、80.51%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223847962798f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223847962798f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","LENZ","BK4139"],"gpt_icon":0},{"id":"2511526364","title":"Tango Therapeutics, Inc.盘中异动 早盘股价大涨5.28%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511526364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511526364?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:39","pubTimestamp":1739457581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时39分，Tango Therapeutics, Inc.股票出现波动，股价快速上涨5.28%。截至发稿，该股报2.59美元/股，成交量2.8443万股，换手率0.03%，振幅3.25%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1021.41%、966.72%、173.76%，振幅较大的相关个股有Moleculin Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Edesa Biotech, Inc.，振幅分别为56.19%、32.86%、30.10%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223942abcdb3c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223942abcdb3c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNGX","LENZ","BK4139"],"gpt_icon":0},{"id":"2510555331","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.10%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510555331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510555331?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:28","pubTimestamp":1739291317,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时28分，Tango Therapeutics, Inc.股票出现异动，股价大幅下跌5.10%。截至发稿，该股报2.59美元/股，成交量30.9105万股，换手率0.29%，振幅3.48%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.57%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2833.79%、1269.78%、421.52%，振幅较大的相关个股有Ocean Biomedical, Inc.、Dominari Holdings Inc.、Omega Therapeutics, Inc.，振幅分别为59.46%、58.60%、49.17%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120028379881d159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120028379881d159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNGX","BK4139"],"gpt_icon":0},{"id":"2510007893","title":"Tango Therapeutics, Inc.盘中异动 股价大跌5.12%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510007893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510007893?lang=zh_cn&edition=full","pubTime":"2025-02-11 02:08","pubTimestamp":1739210886,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日02时08分，Tango Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。截至发稿，该股报2.88美元/股，成交量28.4781万股，换手率0.27%，振幅5.12%。Tango Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Springworks Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3013.28%、1630.30%、1297.77%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Tango Therapeutics, Inc.公司简介：Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211020806abc9d3ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211020806abc9d3ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TNGX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tangotx.com","stockEarnings":[{"period":"1week","weight":0.0428},{"period":"1month","weight":0.5967},{"period":"3month","weight":1.2391},{"period":"6month","weight":1.4442},{"period":"1year","weight":10.1954},{"period":"ytd","weight":1.1986}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tango Therapeutics Inc.于2020年5月21日在特拉华州注册成立，是一家生物技术公司，致力于发现新的药物靶点并提供用于治疗癌症的下一代精准医学。Tango采用一种以患者为起点和终点的方法，利用合成致死的遗传原理来发现和开发针对癌症关键靶点的疗法。这包括将精确肿瘤学目标的范围扩展到新领域，例如肿瘤抑制基因丢失及其对癌细胞逃避免疫细胞杀伤能力的贡献。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.023682},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.080779},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.059423},{"month":4,"riseRate":0.4,"avgChangeRate":-0.023607},{"month":5,"riseRate":0.2,"avgChangeRate":0.026868},{"month":6,"riseRate":0.8,"avgChangeRate":0.293804},{"month":7,"riseRate":0.6,"avgChangeRate":0.025899},{"month":8,"riseRate":1,"avgChangeRate":0.279144},{"month":9,"riseRate":0.6,"avgChangeRate":0.126296},{"month":10,"riseRate":0.166667,"avgChangeRate":0.098632},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.031311},{"month":12,"riseRate":0.5,"avgChangeRate":-0.005187}],"exchange":"NASDAQ","name":"Tango Therapeutics Inc.","nameEN":"Tango Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tango Therapeutics Inc.(TNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tango Therapeutics Inc.,TNGX,Tango Therapeutics Inc.股票,Tango Therapeutics Inc.股票老虎,Tango Therapeutics Inc.股票老虎国际,Tango Therapeutics Inc.行情,Tango Therapeutics Inc.股票行情,Tango Therapeutics Inc.股价,Tango Therapeutics Inc.股市,Tango Therapeutics Inc.股票价格,Tango Therapeutics Inc.股票交易,Tango Therapeutics Inc.股票购买,Tango Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tango Therapeutics Inc.(TNGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tango Therapeutics Inc.(TNGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}